PRESS RELEASE Isis and AstraZeneca Pharmaceuticals.

By working collectively we try to uncover pathways and targets which can be manipulated using antisense medication therapy. B. Lynne Parshall, Chief Working Officer at Isis Pharmaceuticals, said: This growth of our collaboration with AstraZeneca establishes our second strategic romantic relationship. This new collaboration can help broaden the use of our antisense technology to targets in the kidney. AstraZeneca is focused on finding novel best-in-course therapies for a few of the largest, most complicated and fastest developing disease segments in the created world.The medication Tamoxifen has been found in america for over twenty-five years to greatly help in the combat for breast tumor prevention. The medication is used once daily as a tablet and interferes with the feminine hormone estrogen, avoiding it from attaching itself to cells in the breasts tissue. This medication could also be used to take care of women already identified as having breast cancer since it can decelerate or cease the development of cancerous cells.

Other Posts From Category "laboratory":

Related Posts